HUMIRA(CF) PEN 80 MG/0.8 ML

Adalimumab
$6730.5200per EA

Manufacturer

AbbVie Inc.

NDC

00074012402

Classification

Brand

Dosage Form

KIT

Last Updated

4/22/2026

Approval Type

Biologic (BLA)

FDA Application

BLA125057

On Market Since

4/21/2017

Price History

1W

0.0%

1M

+0.0%

3M

-0.0%

6M

-0.0%

1Y

+0.0%

3Y

N/A

5Y

N/A

All

+0.1%

Generic Alternatives

Save up to 50%

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.